Back to company

BIOMOTION PHARMA ApS: Financial statements 2015

CVR: 12928203

BIOMOTION PHARMA ApS (CVR 12928203) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 3,018 and a net result of DKK -1,982 compared with DKK -999 the year before. Equity amounted to DKK -999.

Gross Profit
3,018 kr.
Profit/Loss
-1,982 kr.
Equity
-999 kr.
Total Assets
1 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-3 t.-2 t.-999-
2014--999-999983-
2013-3 t.3 t.2 t.-
2012-3 t.3 t.-1 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2015

BIOMOTION PHARMA ApS: The 2014 annual report is outFeb 27, 2015

BIOMOTION PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -999, and the net result was DKK -999.

About BIOMOTION PHARMA ApS

BIOMOTION PHARMA ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 1989. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANDEL OG INVESTERING AF 1989 ApS and DANSK FARMASAN A/S. The management consists of Henrik Selchau Poulsen. The company is owned by Michael Rasmussen. In 2024, the company reported a gross profit of DKK -5,313 and a net result of DKK -6,460 compared with DKK -1,430 the year before. Equity amounted to DKK 3,310.